Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to investigate the effects of an investigational
medication, called CCX282-B, on safety and on the some of the symptoms of Crohn's Disease in
patients who are experiencing an active flare-up of moderate to severe Crohn's Disease.